Clinical Trial Update: Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating radiotherapy followed by chemotherapy in combination with toripalimab for locally advanced HR-positive, HER2-negative breast cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hr-positive Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: HR-positive,HER2-negative Breast Cancer | Phase 2 | Status: RECRUITING